Prof. Michele de Palma

 

Michele De Palma  obtained in 2004 a PhD Degree in Cell Biotechnologies from the University of Torino Medical School, where he studied the contribution of bone marrow-derived cells to tumor angiogenesis under the direction of gene therapy pioneer, Dr. Luigi Naldini. He obtained Fellowship for 2004-2006 from Italian Association for Cancer Research (AIRC), Young Investigator Award from European Society of Gene Therapy (ESGT) in 2007. He performed his post-doctoral training at the Telethon Institute for Gene Therapy (TIGET) in Milan, where he further characterized the proangiogenic functions of tumor-associated macrophages and developed gene transfer strategies for reprogramming them into antitumoral effector cells. He serves on the editorial/advisory boards of Science Translational Medicine (AAAS), Cell Reports (Cell press), BBA-Reviews on Cancer, Cancer Immunology Research (AACR), and Carcinogenesis. In 2008 he was appointed group leader at the San Raffaele Scientific Institute, Milan. In 2009 he got Starting Grant from European Research Council (ERC). Michele joined the Swiss Institute for Experimental Cancer Research, at the EPFL School of Life Sciences in 2012. The same year he got Anna Fuller Prize, a year later Leenaards Prize and in 2013 he recieved AAAS Wachtel Cancer Research Award (Honorable Mention).